Tag: LAAO

FEops Heartguide receives FDA clearance for LAAO planning capabilities

FEops has announced that it received authorisation from the US Food and Drug Administration (FDA) for FEops Heartguide pre-operative planning of left atrial appendage...

Same-day discharge could become the standard strategy following LAAO

A same-day discharge strategy for left atrial appendage occlusion (LAAO) could become the standard approach for this technique, according to the authors of a...

Study shows LAAO reduces major bleeding and mortality compared with NOACs...

Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score-matched study which examined left atrial appendage occlusion (LAAO) compared with novel...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes versus...

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...

Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute...

Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO) Registry, which enrolled more than 38,000 patients implanted percutaneously with the...
Amplatzer Amulet

Low rates of device-related thrombus found with Amplatzer Amulet occlusion device

Device-related thrombus (DRT) following left atrial appendage occlusion (LAAO) with the Amplatzer Amulet device (Abbott) was “infrequently” observed according to a report published in...